This compound is a tert-butyl carbamate derivative used as a pharmaceutical intermediate in the manufacturing of upadacitinib. It features a pyrrolo[2,3-b]pyrazine core with a 4-methylphenylsulfonyl substituent and a tert-butyloxycarbonyl-protected amine group.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1201187-44-1
Carbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl ester
pharmaceutical intermediate
2-bromo-5H-pyrrolo[2,3-b]pyrazine
Pharmaceutical intermediate for upadacitinib synthesis
(1R)-1-(3-chlorophenyl)ethan-1-ol
pharmaceutical intermediate
Ixazomib Impurity 1
Pharmaceutical intermediate for proteasome inhibitor
N,N',N''-((((1R,1'R,1''R)-(1,3,5,2,4,6-trioxatriborinane-2,4,6-triyl)tris(3-methylbutane-1,1-diyl))tris(azanediyl))tris(2-oxoethane-2,1-diyl))tris(2,5-dichlorobenzamide)
Pharmaceutical intermediate
Methyl 1H-indole-2-carboxylate
pharmaceutical intermediate
2-Bromo-5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazine
Pharmaceutical intermediate for kinase inhibitors
tert-butyl N-[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]carbamate
NTMJGYRFMXFNIC-UHFFFAOYSA-N
CC1=CC=C(C=C1)S(=O)(=O)N2C=CC3=NC(=CN=C32)NC(=O)OC(C)(C)C
—